Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.880959
Abstract: Response to immunotherapy across multiple cancer types is approximately 25%, with some tumor types showing increased response rates compared to others (i.e. response rates in melanoma and non-small cell lung cancer (NSCLC) are typically 30-60%).…
read more here.
Keywords:
immune infiltration;
tumor;
increased tumor;
tumor glycolysis ... See more keywords